Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
CRNX on Nasdaq
Matthew K. Fust - trading volume in the past year for Crinetics Pharmaceuticals, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
21.9K |
$1.04M |
$47.49 |
Jun 7, 2024 |
Direct |
|
|
| Stock Option (right to buy) |
12.5K |
|
|
Jun 7, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.